Skip to content
  • Home
  • contact-rita@ern-net.eu
  • News & Events
  • MeRITA Registry
  • FAQ
  • Contact
  • Facebook
  • LinkedIn
  • Twitter
ERN-RITA

ERN-RITA

European Reference Network for Immunodeficiency, Autoinflammatory, Autimmune and Pediatric Rheumatic disea

The European Reference Network that aims at improving the care of patients with Rare Immunological Disorders
  • Reference centers
  • Disease information
  • Virtual consultations
  • Activities
    • MeRITA Registry
    • Webinars
    • Working Groups
  • Patients
    • ERNs and ePAGs
    • RIPAG
  • About
    • RITA: A Unique Opportunity
    • Mission, Goals and Objectives
    • Governance
    • RITA Membership
    • Scientific societies, stakeholders
    • About ERNS
    • Monitoring
  • Rare diseases
  • Autoinflammatory disorders (AID)
  • Monogenic Inflammatory bowel diseases
Rare diseases
  • Pediatric Rheumatic diseases (PR)
    • Juvenile Arthritis
    • Miscellaneous
    • Systemic autoimmune disease
    • Bone disease
    • Paediatric vasculitis
  • Autoimmune diseases (AI)
    • Autoimmune systemic vasculitis adult and paediatric
    • Autoimmune Neuroinflammation Adult and Paediatric
  • Autoinflammatory disorders (AID)
    • Defects affecting the inflammasome
    • Non inflammasome-related conditions
    • Type 1 Interferonopathies
    • Monogenic Inflammatory bowel diseases
    • Miscellaneous
  • Primary immunodeficiencies (PID)
    • Severe reduction in all serum immunoglobulin isotypes with profoundly decreased or absent B cells
    • Predisposition to severe viral infection
    • Severe reduction in at least 2 serum immunoglobulin isotypes with normal or low number of B cells
    • Herpes simplex encephalitis (HSE)
    • Severe reduction in serum IgG and IgA with normal/elevated IgM and normal numbers of B cells
    • Predisposition to invasive fungal diseases
    • T−B+ Severe Combined Immunodeficiency (SCID)
    • Isotype or light chain deficiencies with generally normal numbers of B cells
    • Chronic mucocutaneous candidiasis (CMC)
    • T−B− SCID DNA recombination defects
    • Familial hemophagocytic lymphohistiocytosis (FHL) syndromes without hypopigmentation
    • TLR signaling pathway deficiency
    • Combined immunodeficiencies generally less profound than severe combined immunodeficiency
    • Familial hemophagocytic lymphohistiocytosis (FHL) syndromes with hypopigmentation
    • Congenital thrombocytopenia
    • T regulatory cells genetic defects
    • DNA repair defects (other than those in group 1)
    • Autoimmunity with or without lymphoproliferation
    • Thymic defects with additional congenital anomalies
    • Autoimmune lymphoproliferative syndrome (ALPS)
    • Immune-osseous dysplasias
    • Immune dysregulation with colitis
    • Hyper-IgE syndromes (HIES)
    • Type 1 Interferonopathies
    • Dyskeratosis congenita (DKC) with bone marrow failure and dysfunctional telomere maintenance
    • Congenital neutropenias
    • Defects of Vitamin B12 and Folate metabolism
    • Defects of Motility
    • Anhidrotic ectodermaldysplasia with immunodeficiency (EDA-ID)
    • Defects of Respiratory Burst
    • Calcium channel defects
    • Medelian Susceptibility to mycobacterial disease (MSMD)
    • Other defects
    • Epidermodysplasia verruciformis

Monogenic Inflammatory bowel diseases

Disease information Hide
LinksFor clinicians and scientistsFor patients
Patient organisations Show
LinksHAE Junior

Diseases

NFAT5 haploinsufficiencyDisease detail IL-10Rβ deficiencyDisease detail IL-10Rα deficiencyDisease detail IL-10 deficiencyDisease detail
→ Access the newsletter archive

Scientific societies & Patient organisations

Network coordination

UMC Utrecht
Heidelberglaan 100
3584 CX Utrecht
Netherlands
VAT NL004205315B01

Follow us & get in touch:

 

The contents of this webpage are the sole responsibility of ERN-RITA and do not necessarily reflect the opinion of the European Union. 

© 2021 ERN RITA. All rights reserved. The RITA logo was designed by Luis Bordalo.